Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Intangibles (2016 - 2025)

Pediatrix Medical (MD) has disclosed Intangibles for 14 consecutive years, with $6.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles fell 53.73% to $6.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.1 million, a 53.73% decrease, with the full-year FY2024 number at $200000.0, down 95.56% from a year prior.
  • Intangibles was $6.1 million for Q3 2025 at Pediatrix Medical, down from $9.3 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $110.0 million in Q4 2022 to a low of $200000.0 in Q4 2024.
  • A 5-year average of $17.9 million and a median of $15.5 million in 2023 define the central range for Intangibles.
  • Biggest YoY gain for Intangibles was 1648.7% in 2023; the steepest drop was 95.91% in 2023.
  • Pediatrix Medical's Intangibles stood at $21.6 million in 2021, then skyrocketed by 410.18% to $110.0 million in 2022, then plummeted by 95.91% to $4.5 million in 2023, then plummeted by 95.56% to $200000.0 in 2024, then surged by 2950.0% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Intangibles are $6.1 million (Q3 2025), $9.3 million (Q2 2025), and $10.4 million (Q1 2025).